Literature DB >> 14561747

The mitochondrial citrate transport protein: probing the secondary structure of transmembrane domain III, identification of residues that likely comprise a portion of the citrate transport pathway, and development of a model for the putative TMDIII-TMDIII' interface.

Chunlong Ma1, Rusudan Kotaria, June A Mayor, Laura R Eriks, Antony M Dean, D Eric Walters, Ronald S Kaplan.   

Abstract

The mitochondrial citrate transport protein (CTP) has been investigated by mutating 28 consecutive residues within transmembrane domain III (TMDIII), one at a time, to cysteine. A cysteine-less CTP that retains wild-type functional properties, served as the starting template. The single Cys CTP mutants were abundantly expressed in Escherichia coli, isolated, and functionally reconstituted in a liposomal system. The accessibility of each single Cys mutant to two methanethiosulfonate reagents was evaluated by determining the rate constants for inhibition of CTP function. These rate constants varied by over five orders of magnitude. With two independent data sets we observed peaks and troughs in the rate constant data at identical amino acid positions and a periodicity of 4 was observed from residues 123-137. Based on the pattern of accessibility we conclude that residues 123-137 exist as an alpha-helix. Although less certain, a combination of the rate constant data and the specific activity data with the single Cys mutants suggests that the alpha-helical secondary structure may extend to residue 113. Furthermore, the rate constant data define water-accessible and water-inaccessible faces of the helix. We infer that the water-accessible face comprises a portion of the substrate translocation pathway through the CTP, whereas the water-inaccessible surface faces the lipid bilayer. Finally, based on a combination of the CTP inhibition rate constant data and the existence of significant sequence identity with a transmembrane segment within glycophorin A that forms a portion of its dimer interface, a model for a putative CTP TMDIII-TMDIII' dimer interface has been developed.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14561747     DOI: 10.1074/jbc.M310866200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  11 in total

1.  Homology-modeled structure of the yeast mitochondrial citrate transport protein.

Authors:  D Eric Walters; Ronald S Kaplan
Journal:  Biophys J       Date:  2004-08       Impact factor: 4.033

2.  The yeast mitochondrial citrate transport protein: molecular determinants of its substrate specificity.

Authors:  Sreevidya Aluvila; Rusudan Kotaria; Jiakang Sun; June A Mayor; D Eric Walters; David H T Harrison; Ronald S Kaplan
Journal:  J Biol Chem       Date:  2010-06-15       Impact factor: 5.157

3.  Identification of the pore-lining residues of the BM2 ion channel protein of influenza B virus.

Authors:  Chunlong Ma; Cinque S Soto; Yuki Ohigashi; Albert Taylor; Vasilios Bournas; Brett Glawe; Maria K Udo; William F Degrado; Robert A Lamb; Lawrence H Pinto
Journal:  J Biol Chem       Date:  2008-04-11       Impact factor: 5.157

4.  Probing the effect of transport inhibitors on the conformation of the mitochondrial citrate transport protein via a site-directed spin labeling approach.

Authors:  June A Mayor; Jiakang Sun; Rusudan Kotaria; D Eric Walters; Kyoung Joon Oh; Ronald S Kaplan
Journal:  J Bioenerg Biomembr       Date:  2010-03-31       Impact factor: 2.945

5.  Structure-function relations of the first and fourth predicted extracellular linkers of the type IIa Na+/Pi cotransporter: I. Cysteine scanning mutagenesis.

Authors:  Colin Ehnes; Ian C Forster; Katja Kohler; Andrea Bacconi; Gerti Stange; Jürg Biber; Heini Murer
Journal:  J Gen Physiol       Date:  2004-11       Impact factor: 4.086

6.  Analysis of the secondary structure of the cys-less yeast mitochondrial citrate transport protein and four single-cys variants by circular dichroism.

Authors:  Michael Cascio; June A Mayor; Ronald S Kaplan
Journal:  J Bioenerg Biomembr       Date:  2004-10       Impact factor: 2.945

7.  Inhibitors of the mitochondrial citrate transport protein: validation of the role of substrate binding residues and discovery of the first purely competitive inhibitor.

Authors:  Sreevidya Aluvila; Jiakang Sun; David H T Harrison; D Eric Walters; Ronald S Kaplan
Journal:  Mol Pharmacol       Date:  2009-10-20       Impact factor: 4.436

8.  A synergistic role of IRP1 and FBXL5 proteins in coordinating iron metabolism during cell proliferation.

Authors:  Nathan B Johnson; Kathryn M Deck; Christopher P Nizzi; Richard S Eisenstein
Journal:  J Biol Chem       Date:  2017-08-02       Impact factor: 5.157

9.  The yeast mitochondrial citrate transport protein: identification of the Lysine residues responsible for inhibition mediated by Pyridoxal 5'-phosphate.

Authors:  Sreevidya Remani; Jiakang Sun; Rusudan Kotaria; June A Mayor; June M Brownlee; David H T Harrison; D Eric Walters; Ronald S Kaplan
Journal:  J Bioenerg Biomembr       Date:  2008-11-11       Impact factor: 2.945

10.  Regional citrate anticoagulation for slow continuous ultrafiltration: risk of severe metabolic alkalosis.

Authors:  Mourad M Alsabbagh; A Ahsan Ejaz; Daniel L Purich; Edward A Ross
Journal:  Clin Kidney J       Date:  2012-04-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.